Endothelin-1 is produced by avascular human amnion tissue and may play a physiological role in human pregnancy, such as in the initiation of labor.
ET-1 amnion production may inform labor physiology; leaves open any clinical role or therapeutic targeting.
Endothelin (ET) was originally isolated from culture medium of porcine aortic endothelial cells as a potent vasoconstrictor peptide.Subsequently, ET was also reported to be produced by nonvascular tissues and to be involved in various biological phenomena in these tissues.Recently, a high concentration of ET-1-like immunoreactivity (ET-1-LI) was found in human amniotic fluid.Amnion tissue also contained a large amount of ET-1-LI, and cultured amnion cells secreted large amounts of ET-1-LI.The major component of ET-1-LI in these samples was ET-1.Moreover, the expression of prepro-ET-1 mRNA was detected in both amnion tissue and cultured amnion cells, indicating that ET-1 in the amniotic fluid originated from amnion cells.In cultured amnion cells, ET-1 secretion was stimulated by EGF, TGF-β, IL-1α, β and TNF-a.In addition, specific receptors for ET, ET-AR and ET-BR were detected in myometrium, decidua vera, chorion laeve, and placenta at term by both ligand binding and Northern blot analysis.These findings suggest that ET-1 secreted from amnion cells plays a physiological role in human pregnancy.In this paper, the regulation of production of ET-1 and expression of receptors for ET-1 by avascular human amnion tissue are reviewed.The possible importance of amniotic ET in human pregnancy is also discussed.
No takes yet. Share an insight, caveat, or question.
Sagawa et al. (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: